#6 Akili's heel; how a deal with The Dictator led to Akili's demise

plus... $8m for Aussie psychedelics, the US company tackling severe mental illness and all the latest news in mental health innovation

Hi friends,

Just 21 months ago, Akili Interactive went public with a valuation of over $500 million. But last week, Akili was sold to Virtual Therapeutics for just $34 million.

What the hell went wrong? What can we learn from another large-scale failure in digital therapeutics? And how did a certain billionaire nicknamed ‘The Dictator’ contribute to their demise?

That’s what we get into in this week’s Deep-Dive.

This week in The Hemingway Report;

  • Akili’s heel: how a deal with The Dictator led to Akili Interactive's demise and what we can learn from the failure

  • More funding for Aussie psychedelics: Psylo closes an $8m seed round

  • Tackling Severe Mental Illness (SMI): the company taking a comprehensive, hands-on approach to caring for people with SMI

  • And all the latest news in mental health innovation

This article is for THR Pro members only

Consider becoming a THR Pro member to access this article as well as more insights, analysis and trends on the mental health industry.

Already a paying subscriber? Sign In.

Reply

or to participate.